The first two principal components (PC) of CMLD1 showed a clear separation between CML and non-CML, as well as between stem (CD34+CD38−) and progenitor cells (CD34+CD38+), as expected (Figure 1b). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.